@article{cc20c37806554f87afe64e5e5c47d24a,
title = "Testosterone pathway genetic polymorphisms in relation to primary open-angle glaucoma: An analysis in two large datasets",
abstract = "Purpose: Sex hormones may be associated with primary open-angle glaucoma (POAG), although the mechanisms are unclear. We previously observed that gene variants involved with estrogen metabolism were collectively associated with POAG in women but not men; here we assessed gene variants related to testosterone metabolism collectively and POAG risk. Methods: We used two datasets: one from the United States (3853 cases and 33,480 controls) and another from Australia (1155 cases and 1992 controls). Both datasets contained densely called genotypes imputed to the 1000 Genomes reference panel. We used pathway- and gene-based approaches with Pathway Analysis by Randomization Incorporating Structure (PARIS) software to assess the overall association between a panel of single nucleotide polymorphisms (SNPs) in testosterone metabolism genes and POAG. In sex-stratified analyses, we evaluated POAG overall and POAG subtypes defined by maximum IOP (high-tension [HTG] or normal tension glaucoma [NTG]). Results: In the US dataset, the SNP panel was not associated with POAG (permuted P = 0.77), although there was an association in the Australian sample (permuted P = 0.018). In both datasets, the SNP panel was associated with POAG in men (permuted P ≤ 0.033) and not women (permuted P ≥ 0.42), but in gene-based analyses, there was no consistency on the main genes responsible for these findings. In both datasets, the testosterone pathway association with HTG was significant (permuted P ≤ 0.011), but again, gene-based analyses showed no consistent driver gene associations. Conclusions: Collectively, testosterone metabolism pathway SNPs were consistently associated with the high-tension subtype of POAG in two datasets.",
keywords = "Genetics, Pathway analysis, Primary open-angle glaucoma, Testosterone",
author = "{Australian and New Zealand Registry of Advanced Glaucoma (ANZRAG) Consortium} and {Cooke Bailey}, {Jessica N.} and Puya Gharahkhani and Kang, {Jae H.} and Mariusz Butkiewicz and Sullivan, {David A.} and Weinreb, {Robert N.} and Hugues Aschard and Allingham, {R. Rand} and Allison Ashley-Koch and Lee, {Richard K.} and Moroi, {Sayoko E.} and Brilliant, {Murray H.} and Gadi Wollstein and Schuman, {Joel S.} and Fingert, {John H.} and Budenz, {Donald L.} and Tony Realini and Terry Gaasterland and Scott, {William K.} and Kuldev Singh and Sit, {Arthur J.} and Igo, {Robert P.} and Song, {Yeunjoo E.} and Lisa Hark and Robert Ritch and Rhee, {Douglas J.} and Douglas Vollrath and Zack, {Donald J.} and Felipe Medeiros and Vajaranant, {Thasarat S.} and Chasman, {Daniel I.} and Christen, {William G.} and Pericak-Vance, {Margaret A.} and Yutao Liu and Peter Kraft and Richards, {Julia E.} and Rosner, {Bernard A.} and Hauser, {Michael A.} and Craig, {Jamie E.} and Burdon, {Kathryn P.} and Hewitt, {Alex W.} and Mackey, {David A.} and Haines, {Jonathan L.} and Stuart Macgregor and Wiggs, {Janey L.} and Pasquale, {Louis R.}",
note = "Funding Information: Support for recruitment of the Australian and New Zealand Registry of Advanced Glaucoma (ANZRAG) was provided by the Royal Australian and New Zealand College of Ophthalmology (RANZCO) Eye Foundation. Funding was provided by the National Health and Medical Research Council (NHMRC) of Australia (No. 535074, 1031362, 1023911, and 1021105). Funding Information: Genotyping services for the NEIGHBOR study were provided by the Center for Inherited Disease Research (CIDR) and were supported by the National Eye Institute through grant HG005259-01 (JLW). Additionally, CIDR is funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. The National Eye Institute (Bethesda, MD, USA) through American Recovery and Reinvestment Act grants 3R01EY015872-05S1 (JLW) and 3R01EY019126–02S1 (MAH) supported the collection and processing of samples for the NEIGHBOR dataset. Funding for the collection of cases and controls was provided by National Institutes of Health (Bethesda, MD, USA) Grants EY015543 (RRA), HG8701 and UL1TR000427 (MHB), EY006827, HL073389, EY13315 (MAH), EY09611, and EY015473 (LRP), EY009149, HG004608, EY008208 (F. Medeiros), EY015473 (LRP), EY012118 (MAP-V), EY015682 (TR), EY011671 (JER), EY09580 (JER), EY013178 (JSS), EY015872 (JLW), EY010886 (JLW), EY009847 (JLW), EY011008 (L. Zangwill), EY144428, EY144448, and EY18660. Funding Information: Supported by the National Institutes of Health Grant EY015473, the Harvard Glaucoma Center of Excellence and Margolis fund (Boston, MA, USA) (LRP, JLW), Research to Prevent Blindness, Inc. (New York, NY, USA) (LRP, JER, JLW), the Arthur Ashley Foundation (LRP), the Glaucoma Research Foundation (San Francisco, CA, USA) (YL), American Health Assistance Foundation (Clarksburg, MD, USA) (YL), and the Glaucoma Foundation (New York, NY, USA) (YL). A Horizon Grant to the Massachusetts Eye and Ear Infirmary from Allergan (Irvine, CA, USA) supported the collection of some glaucoma feature data. Funding Information: The Australian Cancer Study was supported by the Queensland Cancer Fund and the NHMRC of Australia (program number 199600, awarded to David C. Whiteman, Adele C. Green, Nicholas K. Hayward, Peter G. Parsons, David M. Purdie, and Penelope M. Webb and program number 552429, awarded to David C. Whiteman). The Study of Digestive Health was supported by Grant 5 R01 CA 001833 from the US National Cancer Institute (awarded to David C. Whiteman). The Barrett{\textquoteright}s and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS) sponsored the genotyping of cases with esophageal cancer and Barrett{\textquoteright}s esophagus, which were used as unscreened controls in the ANZRAG discovery cohort. BEAGESS was funded by grant R01 CA136725 from the U.S. National Cancer Institute. SM is supported by a Future Fellowship from the Australian Research Council. The Funding Information: The following grants from the National Human Genome Research Institute (Bethesda, MD, USA) supported the Glaucoma Gene Environment Initiative: HG004728 (LRP), HG004424 (Broad Institute to support genotyping), and HG004446 (C. Laurie, University of Washington, for genotype data cleaning and analysis). Publisher Copyright: {\textcopyright} 2018 The Authors.",
year = "2018",
month = feb,
doi = "10.1167/iovs.17-22708",
language = "English (US)",
volume = "59",
pages = "629--636",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "2",
}